Put Options

18 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$84.3 - $94.31 $1.26 Million - $1.41 Million
15,000 Added 197.37%
22,600 $2.09 Million
Q1 2024

May 15, 2024

SELL
$72.54 - $95.56 $1.51 Million - $1.99 Million
-20,800 Reduced 73.24%
7,600 $726,000
Q4 2023

Feb 14, 2024

BUY
$61.71 - $77.76 $1.22 Million - $1.54 Million
19,800 Added 230.23%
28,400 $2.17 Million
Q3 2023

Nov 14, 2023

BUY
$69.28 - $93.38 $48,496 - $65,366
700 Added 8.86%
8,600 $595,000
Q2 2023

Aug 14, 2023

SELL
$81.41 - $94.33 $341,922 - $396,186
-4,200 Reduced 34.71%
7,900 $745,000
Q1 2023

May 15, 2023

BUY
$74.26 - $84.51 $311,892 - $354,942
4,200 Added 53.16%
12,100 $1 Million
Q4 2022

Feb 14, 2023

BUY
$68.3 - $87.44 $539,570 - $690,776
7,900 New
7,900 $589,000
Q2 2022

Aug 15, 2022

SELL
$86.5 - $128.27 $371,950 - $551,561
-4,300 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$101.96 - $128.34 $438,428 - $551,862
4,300 New
4,300 $506,000
Q1 2021

May 17, 2021

SELL
$78.68 - $90.67 $188,832 - $217,608
-2,400 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$71.69 - $91.23 $50,183 - $63,861
700 Added 41.18%
2,400 $219,000
Q1 2020

May 15, 2020

SELL
$52.41 - $81.0 $796,632 - $1.23 Million
-15,200 Reduced 89.94%
1,700 $321,000
Q4 2019

Feb 14, 2020

BUY
$71.7 - $82.09 $996,630 - $1.14 Million
13,900 Added 463.33%
16,900 $3.94 Million
Q2 2019

Aug 14, 2019

SELL
$55.74 - $64.41 $5,574 - $6,441
-100 Reduced 3.23%
3,000 $554,000
Q1 2019

May 15, 2019

SELL
$47.89 - $64.05 $1.91 Million - $2.55 Million
-39,800 Reduced 92.77%
3,100 $593,000
Q3 2018

Nov 14, 2018

BUY
$45.7 - $58.03 $1.32 Million - $1.68 Million
28,900 Added 206.43%
42,900 $7.47 Million
Q2 2018

Aug 14, 2018

BUY
$42.45 - $51.3 $407,520 - $492,480
9,600 Added 218.18%
14,000 $2.04 Million
Q1 2018

May 15, 2018

BUY
$37.19 - $47.45 $163,636 - $208,780
4,400 New
4,400 $614,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.